Leukapheresis Market to Grow at a CAGR of 8.7% to reach US$ 133.90 million from 2021 to 2028
[研究报告] 白细胞分离术市场规模预计将从 2021 年的 7448 万美元增至 2028 年的 1.339 亿美元;预计 2021 年至 2028 年的复合年增长率为 8.7%。
白细胞分离术是一种将参与人体免疫反应的白细胞从血液样本中分离出来的程序。它是一种特殊的血液分离术,在分离过程中,血液中的一种成分(如红细胞或血小板)会被提取出来,而剩余的血液则会重新进入血液循环。白细胞分离术通常用于降低非常高的白细胞 (WBC) 计数,例如慢性血癌,如慢性淋巴细胞白血病 (CLL)。它还可以用于获取白细胞以供以后移植,例如在癌症化疗期间控制白细胞计数的急剧下降。另一种用途是作为一种新型免疫疗法的一部分,称为嵌合抗原受体 (CAR) T 细胞疗法,以帮助对抗白血病、前列腺癌和其他形式的癌症。白细胞分离术可以在申请治疗的人身上完成(自体血液分离术),也可以在捐赠者身上完成,以便以后进行移植(同种异体血液分离术)。目前,白细胞分离术通常用于治疗各种疾病,并且由于它可以增加循环肿瘤细胞的产量,因此也用于诊断目的。自愿献血者人数增加、血液病发病率增加以及老龄人口激增等因素正在推动白细胞分离术市场的增长。然而,白细胞分离术的高成本在一定程度上阻碍了市场的增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
白细胞分离术市场:
Leukapheresis Market: Strategic Insights
Leukapheresis Market
-
CAGR (2021 - 2028)
8.7%
-
Market Size 2021
US$ 74.48 Million
-
Market Size 2028
US$ 133.90 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Asahi Kasei Corporation
- Fresenius SE Co KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
产品类型(白细胞分离设备和白细胞分离一次性用品)
应用(研究应用和治疗应用)
最终用户(血液成分供应商和血液中心、学术和研究机构、制药和生物技术公司以及医院和输血中心)
Leukapheresis Market: Strategic Insights
-
CAGR (2021 - 2028)8.7% -
Market Size 2021
US$ 74.48 Million -
Market Size 2028
US$ 133.90 Million
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Asahi Kasei Corporation
- Fresenius SE Co KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
复合年增长率(2021 - 2028 年)8.7%- 2021 年市场规模
7,448 万美元 - 2028 年市场规模
1.339 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 旭化成公司
- 费森尤斯集团
- 血液透析公司
- 泰尔茂株式会社
- STEMCELL 技术公司
- 血液保健
- 宏科药业
- 全细胞
- 速递
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 白细胞分离术设备和白细胞分离术一次性用品
- 研究应用和治疗应用
- 血液成分供应商和血液中心
- 学术及研究机构
- 制药和生物技术公司
- 医院和输血中心
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
市场洞察
输血是各国国家卫生基础设施和政策不可或缺的一部分。医疗行业的进步促进了严重疾病和伤害的治疗程序的改进,最终推动了输血对患者生存的需求。人们越来越意识到输血的重要性和医疗保健服务中血液的可用性,这导致愿意为医疗事业献血的人数增加。根据世界卫生组织 (WHO) 的数据,2018 年全球报告的献血量约为 1.174 亿次。献血者通常分为自愿无偿献血者、有偿献血者和家庭/替代献血者,根据世卫组织的说法,自愿/无偿献血者是可靠和充足血液供应的主要来源。根据世卫组织 2019 年的数据,从 2008 年到 2015 年,全球 139 个国家的自愿无偿献血者增加了 1160 万。献血趋势在中低收入国家也越来越突出。根据2017年CAG年会上公布的数据,2016年约有1,087名患者接受了13,000次献血手术。自愿献血者数量增幅最大的是东南亚国家(83%)和美洲国家(70%)。
许多国家制定和推行的国家计划进一步吸引了大量血小板和血液捐献者。例如,在印度,国家艾滋病控制组织 (NACO) 下属的国家输血委员会 (NBTC) 是与州艾滋病控制协会 (SACS) 下属的州输血委员会 (SBTC) 进行协调的中央机构。NBTC 支持与输血服务 (BTS) 相关的各种活动的健康计划。因此,世界各国合格捐献者数量的增加促进了对用于分离所需血液成分的白细胞分离设备的需求。
基于产品类型的洞察
根据产品类型,白细胞分离术市场分为白细胞分离术设备和白细胞分离术一次性用品。2021 年,白细胞分离术一次性用品占据了较大的市场份额。然而,白细胞分离术设备部门预计在 2021 年至 2028 年期间将实现更高的复合年增长率。
基于应用的洞察
根据应用,白细胞分离术市场分为研究应用和治疗应用。2021 年,研究应用领域占据了更大的市场份额,预计未来几年该领域的复合年增长率将更高。
基于最终用户的见解
按最终用户划分,白细胞分离术市场分为制药和生物技术公司、学术和研究机构、血液成分供应商和血液中心以及医院和输血中心。2021 年,血液成分供应商和血液中心占据了最大的市场份额。另一方面,医院和输血中心预计在未来几年将实现最高的复合年增长率。
在白细胞分离术市场运营的公司正在采用产品发布、并购、合作、产品创新和产品组合扩展等策略,以扩大其全球影响力、维护品牌名称并满足最终用户日益增长的需求。
白细胞分离术市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 7,448万美元 |
2028 年市场规模 | 1.339亿美元 |
全球复合年增长率(2021 - 2028) | 8.7% |
历史数据 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按产品类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
白细胞分离术市场 – 按产品类型
- 白细胞分离装置
- 血液成分采集设备
- 白细胞分离柱和细胞分离器
- 白细胞减少过滤器
- 白细胞分离术一次性用品
白细胞分离术市场 – 按应用
- 研究应用
- 治疗应用
白细胞分离术市场 – 按最终用户划分
- 制药和生物技术公司
- 学术及研究机构
- 血液成分供应商和血液中心
- 医院和输血中心
白细胞分离术市场 – 按地区划分
北美
- 我们
- 加拿大
- 墨西哥
欧洲
- 法国
- 德国
- 意大利
- 英国
- 西班牙
- 欧洲其他地区
亚太地区 (APAC)
- 中国
- 印度
- 韩国
- 日本
- 澳大利亚
- 亚太其他地区
中东和非洲 (MEA)
- 南非
- 沙特阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲 (SAM)
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区
公司简介
- 旭化成公司
- 费森尤斯集团
- 血液透析公司
- 泰尔茂株式会社
- STEMCELL 技术公司
- 血液保健
- 宏科药业
- 全细胞
- 速递
- 生物体外循环
Leukapheresis Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 74.48 Million |
Market Size by | US$ 133.90 Million |
Global CAGR | 8.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品类型(白细胞分离设备和白细胞分离一次性用品) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The leukapheresis market majorly consists of the players such Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation Terumo Corporation, STEMCELL Technologies Inc., HemaCare, Macopharma, AllCells, STEMEXPRESS, and BioIVT amongst others.
Global leukapheresis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for leukapheresis. The growth of the region is attributed to increasing product launches coupled with increasing patient population.
The Asia Pacific region is expected to account for the fastest growth in the leukapheresis market. Increase in government investments and a number of private biotechnology companies in this region contribute to this dominant share. The rising geriatric population and increasing investment in research are said to be responsible for this growth.
The leukapheresis disposables segment dominated the global leukapheresis market and held the largest revenue share of 61.43% in 2021.
The blood component providers and blood centers segment dominated the global leukapheresis market and accounted for the largest revenue share of 35.03% in 2021.
Key factors that are driving the growth of this market are number of voluntary blood donors, increasing incidence of hematologic diseases, surge in elderly population and growing demand for leukopaks in clinical research activities boost the market growth over the years.
Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields.
The List of Companies - Leukapheresis Market
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.